Skip to content
DraconiticResearch
Search Sources API
220,411 studies31 sourcesUpdated 31 min ago

Oncology

5,767 studies495 in 7 days2,675 in 30 days

Filters
Type
Date
Clear

Latest

5,767 studies

  1. Cross-species spatial profiling links progranulin to an immune suppressive niche in brain metastasis
    N. M. Eskow, K. Prutisto-Chang, M. A. Gomez-Munoz +17
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  2. Comprehensive Pan-Cancer Analysis Reveals the Prognostic, Molecular, and Immunological Significance of EPS8
    A. Juoairia, A. Akter, R. J. Nima +1
    bioRxivPreprintCC BYFull textOncologybioRxiv
  3. Physiological folate levels constrain nucleotide synthesis and increase dependence on nucleotide salvage
    R. Elbashir, K. L. Abbott, D. L. Ramesh +15
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  4. Cross-Source Progression Assessment in Advanced Pancreatic Cancer: An Opportunity-Adjusted Six-State Analysis
    H. A. Jaareh, F. Habash, S. Mustafa +1
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  5. Fatty acid synthase in cardiovascular disease: from molecular mechanisms to therapeutic targeting
    Dina Ibrahim, Mohamed S Zaghloul, Bera Koklu +4
    Cardiovascular ResearchPeer-reviewedPublisher termsFull textOncologyPMC
  6. Combined halp and GRIm scores for risk stratification in metastatic pancreatic ductal adenocarcinoma
    Berkay Yeşilyurt, Ismet Seven, Fahriye Tuğba Köş
    Future OncologyPeer-reviewedLicence not statedFull textOncologyPMC
  7. Spatially resolved multimodal hallmarks of response to neoadjuvant immunotherapies in the melanoma ecosystem in 2D and 3D
    Z. Liu, X. Song, W.-S. Chen +21
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  8. Telmisartan alters the transcriptomes of cancer associated fibroblasts and fibrocytes in a solid tumour model
    C.-M. Lee, N. Telkar, B. J. Wadsworth +9
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  9. Merlin restoration prevents schwannoma progression in a genetically engineered mouse model of NF2-SWN
    J. Vitte, C. Chiasson-MacKenzie, B. K. Cole +2
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  10. From DNA damage to systemic immunity: Interaction networks in radio-immunotherapy.
    Ruixue Huang
    Cell insightPeer-reviewedCC BYFull textOncologyEurope PMC
  11. An AI Model Identifies Chemotherapy Benefit in Node-Negative HR+/HER2- Breast Cancer Patients from TAILORx, a Phase 3 Randomized Clinical Trial
    N. Chan, C. Tang, D. Biswas +14
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  12. MRI Features of Diffuse Glioneuronal Tumor with Oligodendroglioma-like features and Nuclear Clusters: A Case Report and Literature Review
    Dabiao Deng, Chongzhu Fan, Yanying Yang +3
    Current Medical ImagingPeer-reviewedCC BY 4.0Full textOncologyPMC
  13. Non-malignant breast cancer-related breast edema: an overview
    Emily Deehan, Rayya Harb, Harvey Mayrovitz
    Translational Breast Cancer ResearchPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  14. Multi-Modal Kinome Profiling Discovers Mesenchymal-Like Polarity Networks that Underly Directed Hepatocellular Carcinoma Cell Migration
    T. A. Rantso, K. Woods, P. Jensen +11
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  15. Preclinical evaluation of ixazomib for high-risk pediatric brain tumors
    E. Janko, F. M. Walker, M. Slade +10
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  16. Rac1 and CHK1 Converge on Abi-1 to Regulate DNA Repair Dependency and Treatment Response in Human Cancers
    Y. Huang, E. McCulla, J. Park +27
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  17. Inverted logic of ecDNA localization converts nuclear periphery into oncogenic transcription hubs in cancer
    Y. Wang, X. Yan, N. E. Weiser +16
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  18. Na+/K+-ATPase Blockade Reversibly Attenuates Proliferation and Metabolic Function in K562 Human Myelogenous Leukemia Cells
    S. R. Bowden, E. T. Colton, A. D. Norgaard +13
    bioRxivPreprintCC BYFull textOncologybioRxiv
  19. A mechanistic digital twin model for epigenetic therapy optimization in triple-negative breast cancer
    S. Bruno, A. Indeglia, S. Lichterfeld +3
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  20. A therapeutic vulnerability linking MNK1/2 inhibition and G1/S cyclin-dependent kinase blockade in triple-negative breast cancer
    Q. Deng, M. Amiri, A. Moshari +11
    bioRxivPreprintCC BYFull textOncologybioRxiv
  21. ZNF217 promotes receptor tyrosine kinase plasticity and AXL-ERK dependency in ovarian cancer
    M. J. Pandya, J. Hoffman, A. Padmanabhan
    bioRxivPreprintCC BYFull textOncologybioRxiv
  22. DDRKOL: A Focused CRISPR Library for Systematic Identification of DNA Damage Response Dependencies in Glioblastoma
    C. Bayraktar-Odabas, I. Kok, A. Ozbiyik +6
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  23. FKBP9 Drives Hepatocellular Carcinoma EMT by Regulating SEPT6 Transcription and Stability to Activate TGF-β Signaling.
    Yu Zhang, Rixin Su, Jie Zou +4
    International journal of biological sciencesPeer-reviewedCC BYFull textOncologyEurope PMC
  24. CST1 Regulates ER-Mitochondrial Mg²⁺ Balance via MAGT1 to Promote Breast Cancer Metabolism and Growth.
    Wenqiang Gan, Min Zheng, Li Liu +8
    International journal of biological sciencesPeer-reviewedCC BYFull textOncologyEurope PMC
  25. Exon-6 truncated p53 Suppresses Innate Immune Responses to Facilitate Immune Evasion in Bladder Cancer.
    Chi Zhang, Wenjie Wei, Senming Cao +13
    International journal of biological sciencesPeer-reviewedCC BYFull textOncologyEurope PMC